Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
And now, after years of stasis in Silicon Valley, we have SamAltman ... product of unusual self-awareness. Altman, famously, was in the "first class" of YCombinator, Silicon Valley's ur ...
Kevin Zhou's SamAltman, published in November 2024 ... course as YCombinator president. In 2018, YCombinator, still under Altman's leadership, formed its China unit. In 2023, Altman ...
Some results have been hidden because they may be inaccessible to you